Cytokinetics, Incorporated (CYTK) vs Krystal Biotech, Inc. (KRYS)
- Cytokinetics, Incorporated CYTK 61.95 −3.08%
- Krystal Biotech, Inc. KRYS 316.58 −4.07%
Cytokinetics, Incorporated and Krystal Biotech, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and Krystal Biotech, Inc. are of similar size ($9.8B and $8.9B). Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 38.3×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 22.6% against −21.1%. Krystal Biotech, Inc. has the higher net margin (54.8% vs −1,321.1%) and the higher return on invested capital (24.1% vs 0.00%). Across the 16 metrics below, Krystal Biotech, Inc. leads on 14 and Cytokinetics, Incorporated on 2.
Valuation
Profitability
| Metric | CYTK | KRYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.97% | 94.64% | 65.16% |
| Operating margin | (1,046.12%) | 44.89% | 0.00% |
| Net margin | (1,321.12%) | 54.82% | 0.00% |
| Free cash flow margin | (858.16%) | 58.52% | 0.00% |
| Return on equity | 329.76% | 20.12% | (56.36%) |
| Return on assets | (56.76%) | 18.30% | (48.04%) |
| Return on invested capital | 0.00% | 24.07% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack